A gliotoxic factor and multiple sclerosis

被引:31
作者
Ménard, A
Amouri, R
Dobránsky, T
Charriaut-Marlangue, C
Pierig, R
Cifuentes-Diaz, C
Ghandour, S
Belliveau, J
Gascan, H
Hentati, F
Lyon-Caen, O
Perron, H
Rieger, F
机构
[1] INSERM, Lab Neuromodulat Interact & Neuropathol, F-75005 Paris, France
[2] INSERM U29, F-75674 Paris 14, France
[3] CNRS UPR 417, Lab Neurobiol Ontogenet, F-67000 Strasbourg, France
[4] Providence Coll, Dept Chem, Providence, RI 02918 USA
[5] CHU Angers, Biol Cellulaire Lab, F-49033 Angers, France
[6] Hop La Pitie Salpetriere, INSERM U360, F-75013 Paris, France
[7] Federat Neurol, F-75013 Paris, France
[8] Ecole Normale Super Lyon, CNRS, Unite Mixte BioMerieux, UMR 103, F-69364 Lyon, France
[9] Inst Natl Neurol, Tunis 1007, Tunisia
关键词
multiple sclerosis; cytotoxin; apoptosis; cerebrospinal fluid; astrocytes; oligodendrocytes;
D O I
10.1016/S0022-510X(97)00231-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pathogenesis of multiple sclerosis (MS) is unknown. Searching for possible toxic factors, it was found that 3-day exposure to heat-treated cerebrospinal fluid (CSF) from MS patients caused apoptotic death of astrocytes and oligodendrocytes, but not fibroblasts, myoblasts, Schwann cells, endothelial cells and neurons, in vitro. CSFs from other inflammatory or non-inflammatory neurological diseases showed no toxicity. Exposure of these glial cells to partially purified MS CSF produced DNA fragmentation, apoptotic bodies, chromatin condensation, cell shrinkage, and changes in the levels of known cytokines. A cytotoxic factor, called gliotoxin, was characterized chromatographically as a stable 17-kDa glycoprotein. Since this protein is highly cytotoxic for astrocytes and oligodendrocytes, it may represent an initial pathogenic factor, leading to the neuropathological features of MS, such as blood-brain barrier involvement and demyelination. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:209 / 221
页数:13
相关论文
共 42 条
  • [1] Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis
    Bagasra, O
    Michaels, FH
    Zheng, YM
    Bobroski, LE
    Spitsin, SV
    Fu, ZF
    Tawadros, R
    Koprowski, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (26) : 12041 - 12045
  • [2] INCREASED PRODUCTION OF INTERFERON GAMMA AND TUMOR NECROSIS FACTOR PRECEDES CLINICAL MANIFESTATION IN MULTIPLE-SCLEROSIS - DO CYTOKINES TRIGGER OFF EXACERBATIONS
    BECK, J
    RONDOT, P
    CATINOT, L
    FALCOFF, E
    KIRCHNER, H
    WIETZERBIN, J
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 1988, 78 (04): : 318 - 323
  • [3] INDUCTION OF NITRIC-OXIDE SYNTHASE IN DEMYELINATING REGIONS OF MULTIPLE-SCLEROSIS BRAINS
    BO, L
    DAWSON, TM
    WESSELINGH, S
    MORK, S
    CHOI, S
    KONG, PA
    HANLEY, D
    TRAPP, BD
    [J]. ANNALS OF NEUROLOGY, 1994, 36 (05) : 778 - 786
  • [4] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [5] CELL-DEATH BY APOPTOSIS AND ITS PROTECTIVE ROLE AGAINST DISEASE
    BURSCH, W
    OBERHAMMER, F
    SCHULTEHERMANN, R
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (06) : 245 - 251
  • [6] CHUNG IY, 1990, J IMMUNOL, V144, P2999
  • [7] DEVELOPMENTAL CELL-DEATH - MORPHOLOGICAL DIVERSITY AND MULTIPLE MECHANISMS
    CLARKE, PGH
    [J]. ANATOMY AND EMBRYOLOGY, 1990, 181 (03): : 195 - 213
  • [8] COTTRELL JS, 1994, PEPTIDE RES, V7, P115
  • [9] Cell death and birth in multiple sclerosis brain
    Dowling, P
    Husar, W
    Menonna, J
    Donnenfeld, H
    Cook, S
    Sidhu, M
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1997, 149 (01) : 1 - 11
  • [10] FEUTZ AC, 1995, J NEUROCYTOL, V24, P865, DOI 10.1007/BF01179985